CareCloud is trading 5% up at $2.60 after announcing its August 18, 2026 partnership with KabaFusion to build LailaCare, an AI-powered platform for home infusion and specialty pharmacy operations.
- The application will integrate referral intake, eligibility and authorization, patient engagement, and revenue cycle management.
- CareCloud will develop the platform, while KabaFusion will own it.
- The announcement provides no quantified financial forecast.